Reduction of myocardial infarct size by neutrophil depletion: effect of duration of occlusion

American Heart Journal
S R JollyB R Lucchesi

Abstract

Experiments were performed in the dog to examine the effects of neutropenia on ultimate infarct size resulting from short (90 minutes) or prolonged (4 hours) circumflex coronary artery occlusion. Sheep antiserum to canine neutrophils was used to produce neutropenia. Control animals received nonimmune serum. Neutrophil infiltration into myocardial infarcts was examined using histopathologic techniques and a semiquantitative scoring system. In 90-minute occlusions with 24-hour reperfusion, neutropenia was associated with the development of significantly smaller infarcts: normopenic group, 43.2% +/- 3.3% (n = 7) vs. neutropenic group, 26.6% +/- 3.7% (n = 10) of the area at risk, means +/- SEM. However, in 4-hour occlusion with 6-hour reperfusion experiments, the tendency of neutrophil depletion to reduce infarct size did not reach statistical significance (46.4% +/- 7.2% vs. 31.5% +/- 6.0% of the area at risk, normopenic vs. neutropenic) despite differences in neutrophil infiltration into the reperfused region. The observed differences in ultimate infarct size could not be attributed to differences in myocardial oxygen consumption. The results suggest that a significant amount of myocardial infarction induced by a limited duration...Continue Reading

References

Jan 1, 1978·Circulation·R A KlonerE Braunwald
Mar 1, 1978·The Journal of Clinical Investigation·P R MarokoS L Hale
Jun 1, 1978·The Journal of Surgical Research·H BoudoulasJ S Vasko
May 1, 1985·Basic Research in Cardiology·S R JollyB R Lucchesi
Jan 1, 1974·The American Journal of Cardiology·G F BresnahanB E Sobel
Apr 1, 1971·The Journal of Experimental Medicine·J H Hill, P A Ward
Jul 3, 1980·The New England Journal of Medicine·G WeissmannH M Korchak
Aug 21, 1981·Science·R Snyderman, E J Goetzl
Oct 1, 1983·Journal of Molecular and Cellular Cardiology·P S RaoH S Mueller
Nov 1, 1980·The Journal of Clinical Investigation·R N PinckardM S Olson

❮ Previous
Next ❯

Citations

Jun 1, 1992·Cardiovascular Drugs and Therapy·G M Pieper, G J Gross
Jan 1, 1995·Journal of Thrombosis and Thrombolysis·W R HerzogV L Serebruany
Feb 1, 1990·Cardiovascular Drugs and Therapy·A Mazzone, G Ricevuti
Jan 1, 1991·Archives of Toxicology·E Esser, G Loschen
Jul 25, 2012·Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.]·Qiang WangJian-Hua Liu
Oct 12, 2012·European Biophysics Journal : EBJ·Stuart M GrieveGemma A Figtree
Mar 5, 2013·Molecular and Cellular Biochemistry·Bo ShenBo Yang
Oct 12, 2012·Journal of Cardiovascular Translational Research·Slava Epelman, Douglas L Mann
Jan 1, 1992·Molecular Aspects of Medicine·C Rice-Evans, K R Bruckdorfer
Dec 1, 1989·Journal of the American College of Cardiology·R E CarlsonA J Buda
Apr 1, 1989·Journal of the American College of Cardiology·R W Jeremy, L C Becker
Dec 1, 1994·Journal of the American College of Cardiology·Y JangE J Topol
Jan 1, 1988·Free Radical Biology & Medicine·K P Burton
Jan 1, 1988·Free Radical Biology & Medicine·S W Werns, B R Lucchesi
Jan 1, 1990·Free Radical Biology & Medicine·Y T van der SchouwA Hofman
Aug 5, 1996·Transfusion Science·M YonekawaM Adachi
May 1, 1994·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·R CirilloM Prosdocimi
May 1, 1995·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·M IoculanoA P Caputi
Jan 1, 1996·Pharmacology & Therapeutics·F M Williams
Mar 1, 2002·Journal of the American College of Cardiology·Lourdes Sánchez de MiguelAntonio López-Farré
May 1, 1990·Journal of the American College of Cardiology·G L SchaerR Virmani
Jun 4, 1998·Cardiovascular Surgery : Official Journal of the International Society for Cardiovascular Surgery·S P CavanaghS Homer-Vanniasinkam
Jan 1, 1990·Fundamental & Clinical Pharmacology·V J RichardK A Reimer
Nov 4, 1995·Journal of Interventional Cardiology·G C Timmis, E Terrien
Aug 2, 2003·British Journal of Sports Medicine·H Toumi, T M Best
Nov 17, 2007·American Journal of Respiratory and Critical Care Medicine·Larissa DyugovskayaLena Lavie
Sep 28, 2010·American Journal of Respiratory Cell and Molecular Biology·Larissa DyugovskayaLena Lavie
May 1, 1990·The Journal of Clinical Investigation·M L EntmanC W Smith
Sep 1, 1993·The Journal of Clinical Investigation·G L KukielkaD C Anderson

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.